Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-31

FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for Propafenone Hydrochloride from Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propafenone hydrochloride (Propafenone hydrochloride)

Snippet

SUPPL AP for PROPAFENONE HYDROCHLORIDE (PROPAFENONE HYDROCHLORIDE)